| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $4.4M | — |
| R&D Expense | $5.4M | +35.7% |
| SG&A Expense | $8.1M | +25.4% |
| Operating Income | -$12.6M | -20.4% |
| Interest Expense | $8.0M | -46.2% |
| Pre-tax Income | -$20.1M | +20.9% |
| Income Tax | $0 | — |
| Net Income | -$20.1M | +20.9% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | +2.7% |
| Current Assets | $12.6M | +2.7% |
| Total Assets | $13.8M | +6.7% |
| Current Liabilities | $3.8M | -66.8% |
| Stockholders' Equity | $9.9M | +694.0% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | -1.0% |
| Investing Cash Flow | -$855K | -185.6% |
| Financing Cash Flow | $8.1M | -46.3% |